MD Conference Express ADA 2011 - (Page 5)

Features PEER-REVIEWED HIGHLIGHTS FROM THE The European Society of Cardiology 2008 Annual Meeting Munich, Germany August 30—September 4, 2008 6 8 Final results of the SHIELD Study Diabetes: Beyond Just Type 1 and Type 2 Clinical Trial Highlights Peer-Reviewed DIABETES OFFICIAL HIGHLIGHTS FROM THE Scientific Sessions LEAD DIABETES ADVISORS 10 Administration of IV Exenatide to Patients with Sustained Hyperglycemia in the CICU 11 Utilizing Self-Monitored Blood Glucose Data and the ACCORD Trial 11 Major Depression Predicts Total Mortality in ACCORD Trial Participants 12 Continuous Subcutaneous Delivery of Exenatide 13 The Efficacy and Safety of the Novel GPR40 Agonist TAK-875 in Subjects with T2DM 14 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for the Primary Prevention of T2DM 15 Ranibizumab for Vision Loss Due to Diabetic Macular Edema: RISE and RIDE Trial Results Therapeutic Updates Breaking News Therapy Updates Vivian A. Fonseca, MD, FRCP Tulane University, USA Andrew F. Stewart, MD Chair, ADA Scientific Sessions Diabetes: Beyond Just Type 1 and Type 2 Defining diabetes has become more complex than a simple classification of type 1 and type 2. As more is learned about the pathophysiology of the disease, subtle distinctions have been found, which have implications for diagnosis and treatment. Diabetes linked to another disease, or to organ transplantation, may also require a different management strategy. Latent autoimmune diabetes in adults and post-transplant diabetes are two types of so-called "special diabetes" that have become more recognized over the past few years, creating challenges both in appropriate diagnosis and treatment. See page 8. Distribution supported by ALSO IN THIS ISSUE INTERNATIONAL MEDICAL ADVISORY BOARD Heart Institute - Hospital das Eva Gonçalvesova, MD, PhD Clinicas President, Frank C. Messineo, MD Slovak Society of Cardiology New York Hospital Queens Enrique Gurfinkel, MD, PhD Tore Kvien, MD Fundación Favaloro, Argentina Diakonhjemmet Hospital, Mariell Jessup, MD, FAHA Past-President, EULAR Scientific Sessions Program Chair, Michel E. Nussbaum, American Heart Association MD, FACP Milan Luknar, MD New York Hospital Queens National Institute of Cardiovascular Patrick Ying, MD Disease, Slovak Republic NYU Medical Center Raymond Massay, MD President, Joanna J. Wykrzykowska, MD Caribbean Cardiac Society Beth Israel Deaconess Medical Center Anne L. Peters, MD, FACP CDE , • Final results of the SHIELD Study • Clinical Trial Highlights – The Science Behind Diabetes Treatment • Novel Therapies for Type 2 Diabetes Olakunle O. Akinboboye, ADVISORY BOARD INTERNATIONAL MEDICAL MD Roberto R. Giraldez, MD New York Hospital Queens Edmund Chada Baracat, MD Martin J. Abrahamson, MD Scientific Director, Beth Israel Deaconess Brazilian Medical Association Medical Center Jeroen J. Bax, MD, PhD Joslin Diabetes Center Leiden University Medical Center Heinz Burgmann, MD The Netherlands University Bergenstal, MD Richard M.of Vienna Harold Medicine & Science, President, J. Burstein, MD, PhD American Diabetes Association Dana-Farber Cancer Insitute Marc P. Bonaca, MD, MPH PhD Daniel J. DeAngelo, MD, Brigham and Women's Hospital, USA Dana-Farber Cancer Institute RamonW. Falk, MD, MS Gary Corbalán, MD Pontificia Universidad Católica, Chile Cleveland Clinic Anthony J. Dalby MB, ChB, FCP Apostolos Georgopoulos, MD Vice President, Vienna University of South African Univ. of Southern California, USA Society of Cardiac Practitioners Robert P Giugliano, MD, SM . Fausto Pinto, MD Jean-Pierre Després, PhD Brigham & Women’s Hospital CPC Chair, European Society of Université Laval, Canada Cardiology Congress 2009-2010 Timothy J. Gardner, MD Jacob A. Udell, MD, MPH Christiana Care Center for Brigham and Women's Hospital, USA Heart & Vascular Health Robert P Giugliano, MD, SM . Publisher Jennifer Goodwin Brigham and Women’s Hospital, USA Vice President, Beth Johnson Publishing Associate Director, Heather Q. Sinclair STAFF Publishing President Jennifer Goodwin Schünemann Production Assistant Lauren Valone Vice President, Beth Johnson Neil Canavan Medical Writers Publishing MedCom Depot Production Manager Lauren Valone Design IntuitDesign Lori Alexander Medical Writers Rita Buckley PUBLISHER 16 Platelets in Diabetes 22 Novel Therapies for T2DM 25 Drug Induced Dysglycemia 28 Diabetes & Atherosclerosis Other News 98 Oxford Street Suite #1 Arlington, MA 02474 USA Tel.: +1-617-515-9797 E-mail: reports [at] goodwingroupintl.com EDITORIAL STAFF 30 Obstructive Sleep Apnea 31 Rapid and Ultrafast Acting Insulins 32 Four Year Outcomes of an Intensive Lifestyle Intervention in T2DM 32 Bariatric Surgery in the Pediatric Population 33 Overview for Immunotherapy Trials Aimed at Preventing Loss and Preserving Beta Cell Mass 34 Biomarkers of Early Diabetic Nephropathy SALES BUSINESS DEVELOPMENT Jennifer Goodwin Schünemann Jennifer Goodwin Tel.: +1-617-515-9797 Tel.: +1-617-515-9797 www.mdconferencexpress.com reports [at] goodwingroupintl.com +1-617-515-9797 The publisher does not assume any legal liability or responsibility for the accuracy, completeness, or usefulness of the information supplied herein, nor for any opinion expressed. The publisher, its agents, and employees will not be liable for any loss or damage arising directly or indirectly from the possession, publication, use of, or reliance on information obtained from this report. It is provided in good faith without express or implied warranty. Reference to any specific commercial product or service does not imply endorsement or recommendation by the publisher. All articles are peer-reviewed and protected from any commercial influence. More peer-reviewed medical conference highlights Subscribe here © MD Conference Express. All rights reserved. Neither this publication nor any part of it may be reproduced, stored in a retrieval system, or transmitted in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of The Goodwin Group International, LLC. MD Conference Express is a registered trademark of The Goodwin Group International, LLC. ISSN 1559-8977 ISSN 2155-756X  http://www.mdconferencexpress.com http://professional.diabetes.org/Congress_Display.aspx?TYP=9&CID=82452 http://www.goodwingroupintl.com http://visitor.r20.constantcontact.com/manage/optin/ea?v=001BdwJNcIEVTgv4LtUJBUDeg%3D%3D http://www.mdconferencexpress.com/yearlysubscribe.html http://www.facebook.com/mdconferencexpress http://www.mdconferencexpress.com http://www.goodwingroupintl.com

Table of Contents for the Digital Edition of MD Conference Express ADA 2011

MD Conference Express ADA 2011

https://www.nxtbook.com/nxtbooks/md_conference_express/ada2011
https://www.nxtbookmedia.com